VRAX
Virax Biolabs Group Limited
2.78
5 x 2.45
1 x 3.33
bid
ask
+
0.04
1.46%
10:16 AM
timesize
| Ytd | -67.86% | |
| 1y | -87.07% |
2.69
day range
2.91
2.50
52 week range
28.50
| Open | 2.70 | Prev Close | 2.74 | Low | 2.69 | High | 2.91 | Mkt Cap | 2.26M |
| Vol | 64.91K | Avg Vol | 1.15M | EPS | -30.50 | P/E | N/A | Forward P/E | -1.01 |
| Beta | 1.93 | Short Ratio | 0.11 | Inst. Own | 5.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.35 | 200-d Avg | 8.21 | 1yr Est | 20.00 |
| Income Statement | |||
| Weighted Average Shares | 190.52K | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.35M | ||
| Cash and Equivalents (USD) | 3.35M | ||
| Trade and Non-Trade Receivables | 729.00 | ||
| Current Assets | 4.15M | ||
| Property, Plant & Equipment Net | 1.57M | ||
| Total Assets | 5.72M | ||
| Debt Current | 261.95K | ||
| Total Debt | 537.99K | ||
| Current Liabilities | 365.47K | ||
| Debt Non-Current | 276.04K | ||
| Total Liabilities | 641.52K | ||
| Accumulated Retained Earnings (Deficit) | -26.93M | ||
| Accumulated Other Comprehensive Income | -55.25K | ||
| Shareholders Equity | 5.31M | ||
| Shareholders Equity (USD) | 5.31M | ||
| Assets Non-Current | 1.57M | ||
| Total Debt (USD) | 537.99K | ||
| Inventory | 54.19K | ||
| Liabilities Non-Current | 276.04K | ||
| Trade and Non-Trade Payables | 103.52K | ||
| Tax Assets | 174.97K | ||